ストックスクリーナーアプリを入手
1.32
3.13%
0.04
アフターアワーズ：
1.34
0.02
+1.52%
前日終値:
$1.28
開ける：
$1.28
24時間の取引高:
114.68K
Relative Volume:
0.25
時価総額：
$60.36M
収益：
$19.94M
当期純損益:
$-37.37M
株価収益率:
-1.2692
EPS:
-1.04
ネットキャッシュフロー:
$-33.38M
1週間 パフォーマンス:
-0.75%
1か月 パフォーマンス:
-5.71%
6か月 パフォーマンス:
-4.35%
1年 パフォーマンス:
-40.00%
1日の値動き範囲:
$1.28
$1.37
1週間の範囲:
$1.20
$1.37
52週間の値動き範囲:
$0.595
$4.18
Werewolf Therapeutics Inc Stock (HOWL) Company Profile
名前
Werewolf Therapeutics Inc
セクター
電話
617-952-0555
住所
200 TALCOTT AVENUE, WATERTOWN
HOWL を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
HOWL
Werewolf Therapeutics Inc
|
1.32 | 59.68M | 19.94M | -37.37M | -33.38M | -1.04 |
|
VRTX
Vertex Pharmaceuticals Inc
|
395.12 | 99.96B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
589.48 | 60.83B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
454.38 | 59.89B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
660.00 | 40.47B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
313.67 | 37.96B | 3.81B | -644.79M | -669.77M | -6.24 |
Werewolf Therapeutics Inc Stock (HOWL) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2024-04-03 | 開始されました | JMP Securities | Mkt Outperform |
| 2023-08-24 | 開始されました | Wedbush | Outperform |
| 2023-06-06 | 再開されました | Jefferies | Buy |
| 2021-09-10 | 開始されました | BofA Securities | Buy |
| 2021-05-25 | 開始されました | Evercore ISI | Outperform |
| 2021-05-25 | 開始されました | H.C. Wainwright | Buy |
| 2021-05-25 | 開始されました | Jefferies | Buy |
| 2021-05-25 | 開始されました | SVB Leerink | Outperform |
すべてを表示
Werewolf Therapeutics Inc (HOWL) 最新ニュース
What momentum shifts mean for Werewolf Therapeutics Inc.2025 Earnings Impact & Free Technical Pattern Based Buy Signals - Newser
Will Werewolf Therapeutics Inc. stock benefit from AI tech trends2025 Key Highlights & Daily Profit Maximizing Trade Tips - Newser
Statistical indicators supporting Werewolf Therapeutics Inc.’s strengthMarket Growth Review & Capital Protection Trading Alerts - Newser
Is Werewolf Therapeutics Inc. stock poised for growthEarnings Beat & Technical Buy Zone Confirmation - Newser
Is Werewolf Therapeutics Inc. meeting your algorithmic filter criteriaTreasury Yields & Weekly Hot Stock Watchlists - Newser
What recovery options are there for Werewolf Therapeutics Inc.2025 Technical Overview & Low Drawdown Trading Strategies - Newser
Why Werewolf Therapeutics Inc. stock attracts strong analyst attentionJuly 2025 Volume & Daily Chart Pattern Signal Reports - beatles.ru
Smart tools for monitoring Werewolf Therapeutics Inc.’s price actionJuly 2025 Market Mood & AI Forecasted Stock Moves - Newser
How to monitor Werewolf Therapeutics Inc. with trend dashboards2025 Trade Ideas & Weekly Hot Stock Watchlists - Newser
Custom watchlist performance reports with Werewolf Therapeutics Inc.GDP Growth & Verified High Yield Trade Plans - Newser
Strategies to average down on Werewolf Therapeutics Inc.2025 Bull vs Bear & Daily Oversold Bounce Ideas - Newser
Werewolf Therapeutics Inc. stock momentum explained2025 Market Outlook & Daily Volume Surge Trade Alerts - Newser
Using Bollinger Bands to evaluate Werewolf Therapeutics Inc.2025 Retail Activity & Low Drawdown Investment Strategies - Newser
Can momentum traders help lift Werewolf Therapeutics Inc.2025 Volatility Report & Low Drawdown Trading Techniques - Newser
What is HC Wainwright’s Estimate for HOWL Q3 Earnings? - Defense World
When is the best time to exit Werewolf Therapeutics Inc.Earnings Miss & Short-Term High Return Strategies - Newser
How institutional ownership impacts Werewolf Therapeutics Inc. stockEntry Point & Free Verified High Yield Trade Plans - Newser
Werewolf Therapeutics Faces Regulatory and Financial Challenges Amid FDA Disruptions - MSN
Real time alert setup for Werewolf Therapeutics Inc. performanceJuly 2025 Market Mood & Daily Oversold Stock Bounce Ideas - Newser
Why Werewolf Therapeutics Inc. is moving todayEarnings Recap Summary & Weekly Top Gainers Trade List - Newser
AI Tools Suggest Werewolf Therapeutics Inc. May Outperform This Week - sundaytimes.kr
Relative strength of Werewolf Therapeutics Inc. in sector analysisJuly 2025 Levels & Community Trade Idea Sharing Platform - Newser
Werewolf Reports No Revenue in Fiscal Q2 - AOL.com
Analyzing Werewolf Therapeutics Inc. with multi timeframe chartsDollar Strength & Fast Entry High Yield Stock Tips - Newser
Using Python tools to backtest Werewolf Therapeutics Inc. strategies2025 Market Sentiment & Short-Term High Return Ideas - Newser
Is Werewolf Therapeutics Inc. Stock a Good Fit for Conservative InvestorsJuly 2025 Price Swings & High Conviction Trade Alerts - Newser
Using data filters to optimize entry into Werewolf Therapeutics Inc.Market Trend Review & Community Verified Watchlist Alerts - Newser
Full technical analysis of Werewolf Therapeutics Inc. stockEarnings Overview Summary & AI Forecast Swing Trade Picks - Newser
Short interest data insights for Werewolf Therapeutics Inc.2025 Geopolitical Influence & Capital Protection Trading Alerts - Newser
Using economic indicators to assess Werewolf Therapeutics Inc. potentialPortfolio Profit Report & Smart Allocation Stock Tips - Newser
Is Werewolf Therapeutics Inc. backed by strong institutional buyingWeekly Earnings Recap & Smart Investment Allocation Insights - sundaytimes.kr
Using data models to predict Werewolf Therapeutics Inc. stock movementJobs Report & Technical Pattern Based Buy Signals - Newser
Werewolf Therapeutics reports Q2 EPS (40c), consensus (37c) - MSN
Werewolf Therapeutics Reports Q2 2025 Financial Results - MSN
Werewolf Therapeutics Inc (HOWL) 財務データ
収益
当期純利益
現金流量
EPS
Werewolf Therapeutics Inc (HOWL) インサイダートレーディング
| インサイダートレーディング | 関係 | 日付 | 取引 | コスト | #株式 | 値 ($) | #株式総数 |
|---|---|---|---|---|---|---|---|
| RA CAPITAL MANAGEMENT, L.P. | Director |
May 14 '25 |
Buy |
0.98 |
162,539 |
159,288 |
6,237,482 |
| RA CAPITAL MANAGEMENT, L.P. | Director |
May 13 '25 |
Buy |
0.98 |
52,974 |
51,915 |
6,074,943 |
| MPM BioVentures 2014, L.P. | 10% Owner |
Mar 27 '25 |
Sale |
1.05 |
1,963 |
2,061 |
3,208,793 |
| EVNIN LUKE | Director |
Mar 27 '25 |
Sale |
1.05 |
2,425 |
2,546 |
4,309,860 |
| GADICKE ANSBERT | 10% Owner |
Mar 27 '25 |
Sale |
1.05 |
4,386 |
4,605 |
6,718,670 |
0.94%
1.72%
大文字化:
|
ボリューム (24 時間):